Controlled Human Infection Models for Schistosomiasis in Uganda (360G-Wellcome-209337_Z_17_Z)
Our goal is to establish a controlled human infection model (CHIM) for schistosomiasis in Uganda, with a view to advancing vaccine development for this important parasitic infection. The objective of this proposal is to engage with, and inform, relevant stakeholders in Uganda about controlled human infection models through \- A visit to Leiden. Four to five key Ugandan personnel will visit Leiden University Medical Centre where the CHIM for schistosomiasis has been established to observe procedures. \- A stakeholder meeting in Uganda. Key stakeholders will be invited to a 2.5 day meeting to learn about CHIMs, and to discuss ethical, regulatory and practical procedures in relation to an outline proposal to establish the model in Uganda.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | International |
| Award Date | 2017-09-30T00:00:00+00:00 |
| Internal ID | 209337/Z/17/Z |
| Planned Dates: End Date | 2018-08-14T00:00:00+00:00 |
| Planned Dates: Start Date | 2017-08-15T00:00:00+00:00 |
| Amount Awarded | 36507 |
| Financial Year | 2016/17 |
| Lead Applicant | Prof Alison Elliott |
| Grant Programme: Title | Discretionary Award - Vaccines |
| Applicant Surname | Elliott |
| Approval Committee | Internal Decision Panel |
| Recipient Org: Country | Uganda |
| Recipient Org: City | Entebbe |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | No |
| Total amount including partnership funding | 36507 |